Study of 3 different dosages i.e Itraconazole 100mg vs 200mg vs 400mg or 5mg/kg whichever is lower in treatment of dermatophytosis (Ringworm)
Not Applicable
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2020/08/027063
- Lead Sponsor
- SOA university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All naive cases of dermatophytosis
2.Potassium hydroxide (KOH) positive cases
3.Treated cases but off treatment from
topical/systemic antifungal for the last
four weeks
Exclusion Criteria
1.Pregnant or lactating females.
2.History of diabetes.
3.Immunosuppressed patients.
4.Patient on drugs that interfere with
itraconazole metabolism
5.History of hepatic and renal impairment.
6.Cases of congestive heart failure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method KOH status <br/ ><br>Culture status <br/ ><br>Clinical clearanceTimepoint: Outcome will be assessed after completion of study in june 2021.
- Secondary Outcome Measures
Name Time Method Safety profileTimepoint: In terms of side effects of the drug at 4th week and 6th week